Literature DB >> 27900012

Ubenimex enhances the radiosensitivity of renal cell carcinoma cells by inducing autophagic cell death.

Shuai Liu1, Xiaoqing Wang1, Jiaju Lu1, Liping Han2, Yongfei Zhang3, Zheng Liu1, Sentai Ding1, Zhao Liu1, Dongbin Bi1, Zhihong Niu1.   

Abstract

Renal cell carcinoma (RCC) is resistant to standard radiotherapy. Ubenimex, an aminopeptidase N inhibitor, is widely used as an adjunct therapy after surgery to enhance the function of immunocompetent cells and confer antitumor effects. Our previous study demonstrated that ubenimex induces autophagic cell death in RCC cells. Recently, the molecular mechanism of autophagy induction has been associated with radiosensitivity in RCC cells. In the present study, the ability of ubenimex to enhance RCC cell sensitivity to radiation via the induction of autophagic cell death was determined, and the mechanism of action of this effect was investigated. The 786-O and OS-RC-2 human RCC cell lines were treated with 0.5 mg/ml ubenimex and different doses of irradiation (IR). The cell viability was measured using a colony-formation assay and flow cytometry. Acridine orange (AO)-ethidium bromide (EB) staining was assessed by fluorescence microscopy as an indicator of autophagic cell death. Protein expression was assessed by western blotting. Autophagosomes were evaluated using transmission electron microscopy. RCC cells were used to evaluate the sensitivity to radiation using clonogenic survival and lactate dehydrogenase assays. Furthermore, these parameters were also tested at physiological oxygen levels. The AO-EB staining and flow cytometry of the OS-RC-2 cells indicated that the combined treatment significantly enhanced autophagic cell death compared with ubenimex or IR alone. Therefore, treatment with ubenimex did not significantly alter cell cycle progression but increased cell death when combined with radiation. An Akt agonist could significantly weaken this effect, indicating that ubenimex may act as an Akt inhibitor. Furthermore, the western blot analysis indicated that the combined treatment inhibited the Akt signaling pathway compared with ubenimex treatment or IR alone. Ubenimex may enhance RCC cell sensitivity to radiation by inducing cell autophagy. This induction changes the role of autophagy from protective to lethal in vitro, and this switch is associated with the inhibition of the Akt signaling pathway.

Entities:  

Keywords:  Akt; RCC; autophagic cell death; radiosensitivity; ubenimex

Year:  2016        PMID: 27900012      PMCID: PMC5103958          DOI: 10.3892/ol.2016.5036

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  42 in total

1.  Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer.

Authors:  Chi-Iou Lin; Edward E Whang; David B Donner; Jinyan Du; Jochen Lorch; Frank He; Xiaofeng Jiang; Brendan D Price; Francis D Moore; Daniel T Ruan
Journal:  Mol Cancer Res       Date:  2010-08-24       Impact factor: 5.852

2.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

3.  Pharmacological enhancement of autophagy induced in a hepatocellular carcinoma cell line by high-LET radiation.

Authors:  Anaïs Altmeyer; Alain C Jung; Mihaela Ignat; Sami Benzina; Jean-Marc Denis; John Gueulette; Georges Noël; Didier Mutter; Pierre Bischoff
Journal:  Anticancer Res       Date:  2010-02       Impact factor: 2.480

4.  PM02734 (elisidepsin) induces caspase-independent cell death associated with features of autophagy, inhibition of the Akt/mTOR signaling pathway, and activation of death-associated protein kinase.

Authors:  Yi-He Ling; Miguel Aracil; Yiyu Zou; Ziqiang Yuan; Bo Lu; José Jimeno; Ana Maria Cuervo; Roman Perez-Soler
Journal:  Clin Cancer Res       Date:  2011-06-20       Impact factor: 12.531

5.  Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated.

Authors:  Shuai Liu; Fang Xie; Hafeng Wang; Zheng Liu; Xiaowen Liu; Liang Sun; Zhihong Niu
Journal:  Oncol Rep       Date:  2014-12-23       Impact factor: 3.906

Review 6.  Role of autophagy in cancer.

Authors:  Robin Mathew; Vassiliki Karantza-Wadsworth; Eileen White
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

7.  The effect of gartanin, a naturally occurring xanthone in mangosteen juice, on the mTOR pathway, autophagy, apoptosis, and the growth of human urinary bladder cancer cell lines.

Authors:  Zhongbo Liu; Mitchell Antalek; Linda Nguyen; Xuesen Li; Xuejiao Tian; Amy Le; Xiaolin Zi
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

8.  Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation.

Authors:  Maria Rajecki; Taija af Hällström; Tanja Hakkarainen; Petri Nokisalmi; Sampsa Hautaniemi; Anni I Nieminen; Mikko Tenhunen; Ville Rantanen; Reneé A Desmond; Dung-Tsa Chen; Kilian Guse; Ulf-Håkan Stenman; Ricardo Gargini; Mika Kapanen; Juha Klefström; Anna Kanerva; Sari Pesonen; Laura Ahtiainen; Akseli Hemminki
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

9.  Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma.

Authors:  Bo Zhai; Fengli Hu; Xian Jiang; Jun Xu; Dali Zhao; Bing Liu; Shangha Pan; Xuesong Dong; Gang Tan; Zheng Wei; Haiquan Qiao; Hongchi Jiang; Xueying Sun
Journal:  Mol Cancer Ther       Date:  2014-04-04       Impact factor: 6.261

10.  Hepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF/c-Met/Akt and Jak2/Stat3 pathways.

Authors:  Weibo Chen; Junhua Wu; Hua Shi; Zhongxia Wang; Guang Zhang; Yin Cao; Chunping Jiang; Yitao Ding
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

View more
  7 in total

Review 1.  Role of autophagy in regulating the radiosensitivity of tumor cells.

Authors:  Yong Xin; Fan Jiang; Chunsheng Yang; Qiuyue Yan; Wenwen Guo; Qian Huang; Longzhen Zhang; Guan Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-07       Impact factor: 4.553

2.  Design, Synthesis, and Biological Evaluation of APN and AKT Dual-Target Inhibitors.

Authors:  Qian Liu; Hang Dong; Wei Zhao; Guozhen Zhang; Shunda Li; Qifu Xu; Yingjie Zhang
Journal:  ACS Med Chem Lett       Date:  2021-11-10       Impact factor: 4.345

3.  Autophagy flux inhibition, G2/M cell cycle arrest and apoptosis induction by ubenimex in glioma cell lines.

Authors:  Liping Han; Yongfei Zhang; Shuai Liu; Qingwei Zhao; Xianhong Liang; Zhiguo Ma; Prakash K Gupta; Miaoqing Zhao; Aihua Wang
Journal:  Oncotarget       Date:  2017-11-21

4.  Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells.

Authors:  Liping Han; Qingwei Zhao; Xianhong Liang; Xiaoqing Wang; Zhen Zhang; Zhiguo Ma; Miaoqing Zhao; Aihua Wang; Shuai Liu
Journal:  Oncotarget       Date:  2017-07-11

5.  Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells.

Authors:  Xiaoqing Wang; Yang Liu; Rongde Wu; Feng Guo; Lijuan Zhang; Mingyu Cui; Xiangyu Wu; Yongfei Zhang; Wei Liu
Journal:  Onco Targets Ther       Date:  2018-02-22       Impact factor: 4.147

6.  Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway.

Authors:  Yanjun Wang; Bo Pang; Rui Zhang; Yibing Fu; Qi Pang
Journal:  Drug Des Devel Ther       Date:  2019-09-12       Impact factor: 4.162

7.  In Vivo Molecular Imaging of the Efficacy of Aminopeptidase N (APN/CD13) Receptor Inhibitor Treatment on Experimental Tumors Using 68Ga-NODAGA-c(NGR) Peptide.

Authors:  Adrienn Kis; Noémi Dénes; Judit P Szabó; Viktória Arató; Lívia Beke; Orsolya Matolay; Kata Nóra Enyedi; Gábor Méhes; Gábor Mező; Péter Bai; István Kertész; György Trencsényi
Journal:  Biomed Res Int       Date:  2021-03-10       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.